TY - GEN
T1 - Collaborative stakeholders approach in combating substandard and falsified medical products in Indonesia
T2 - 3rd International Symposium of Biomedical Engineering''s Recent Progress in Biomaterials, Drugs Development, and Medical Devices, ISBE 2018
AU - Handayani, Retty Dwi
AU - Purwadianto, Agus
AU - Magenda, Burhan Djabir
N1 - Funding Information:
The author gratefully acknowledges BPOM for financial support. This research material may appear in the thesis of the author.
Publisher Copyright:
© 2019 Author(s).
PY - 2019/4/9
Y1 - 2019/4/9
N2 - The presence of substandard and falsified (SF) medical product at a significant level has become one of the threat to public health in Indonesia. BPOM as National Regulatory Authority in Indonesia has developed and implemented a policies to prevent, detect and act towards SF medical product. Nevertheless, these policies implementation has not effective to eliminate the threat. This study aimed to explore the gap exists in the policy implementation and develop a strategy using collaborative stakeholder approach among government institution and non-government organization. The study analyzes fact and data gathered by using in-depth interviews qualitatively involving 7 participants from two different categories. As a result, there are two main factors: 1) A different perception amongst the participants and 2) An obstacles to the policy implementation. Participants from non-government organization agreed that to eradicate SF required stakeholder collaboration to overcome the challenges. Furthermore, this study proposed an SF task force nationally model to empower the stakeholder's capacity, especially civil society, by implementing the science-technology-society concept. Through this model, the task force can mobilize resources response to every SF medical problems.
AB - The presence of substandard and falsified (SF) medical product at a significant level has become one of the threat to public health in Indonesia. BPOM as National Regulatory Authority in Indonesia has developed and implemented a policies to prevent, detect and act towards SF medical product. Nevertheless, these policies implementation has not effective to eliminate the threat. This study aimed to explore the gap exists in the policy implementation and develop a strategy using collaborative stakeholder approach among government institution and non-government organization. The study analyzes fact and data gathered by using in-depth interviews qualitatively involving 7 participants from two different categories. As a result, there are two main factors: 1) A different perception amongst the participants and 2) An obstacles to the policy implementation. Participants from non-government organization agreed that to eradicate SF required stakeholder collaboration to overcome the challenges. Furthermore, this study proposed an SF task force nationally model to empower the stakeholder's capacity, especially civil society, by implementing the science-technology-society concept. Through this model, the task force can mobilize resources response to every SF medical problems.
KW - Indonesia
KW - public health
KW - science-technology-society
KW - substandard and falsified medical product
UR - http://www.scopus.com/inward/record.url?scp=85064825837&partnerID=8YFLogxK
U2 - 10.1063/1.5096737
DO - 10.1063/1.5096737
M3 - Conference contribution
AN - SCOPUS:85064825837
T3 - AIP Conference Proceedings
BT - 3rd Biomedical Engineering''s Recent Progress in Biomaterials, Drugs Development, and Medical Devices
A2 - Wulan, Praswasti P.D.K.
A2 - Gozan, Misri
A2 - Astutiningsih, Sotya
A2 - Ramahdita, Ghiska
A2 - Dhelika, Radon
A2 - Kreshanti, Prasetyanugraheni
PB - American Institute of Physics Inc.
Y2 - 6 August 2018 through 8 August 2018
ER -
